Author/Creator: Cheng, Michael L. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Cheng, Michael L.

1. Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab. Issue 1 (February 2020)

Authors:: Postow, Michael A.; Chasalow, Scott D.; Kuk, Deborah; Panageas, Katherine S.; Cheng, Michael L.; Yuan, Jianda; Wolchok, Jedd D.
Journal:: Melanoma research
Issue:: Volume 30:Issue 1(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions. (9th November 2020)

Authors:: Cheng, Michael L.; Pectasides, Eirini; Hanna, Glenn J.; Parsons, Heather A.; Choudhury, Atish D.; Oxnard, Geoffrey R.
Journal:: CA
Issue:: Volume 71:Number 2(2021)
Page Start:: 176
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas. (February 2020)

Authors:: Sands, Jacob M.; Nguyen, Tom; Shivdasani, Priyanka; Sacher, Adrian G.; Cheng, Michael L.; Alden, Ryan S.; Jänne, Pasi A.; Kuo, Frank C.; Oxnard, Geoffrey R.; Sholl, Lynette M.
Journal:: Lung cancer
Issue:: Volume 140(2020)
Page Start:: 35
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Plasma cfDNA Genotyping in Hospitalized Patients With Suspected Metastatic NSCLC. (2021)

Authors:: Cheng, Michael L.; Milan, Marina S. D.; Tamen, Rubii M.; Bertram, Arrien A.; Michael, Kesi S.; Ricciuti, Biagio; Kehl, Kenneth L.; Awad, Mark M.; Sholl, Lynette M.; Paweletz, Cloud P.; Jänne, Pasi A.
Journal:: JCO precision oncology
Issue:: Volume 5(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC. (December 2021)

Authors:: Cheng, Michael L.; Lau, Christie J.; Milan, Marina S. D.; Supplee, Julianna G.; Riess, Jonathan W.; Bradbury, Penelope A.; Jänne, Pasi A.; Oxnard, Geoffrey R.; Paweletz, Cloud P.
Journal:: JCO precision oncology
Issue:: Volume 5(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. The incidence of oesophageal cancer in Eastern Africa: Identification of a new geographic hot spot?. Issue 2 (April 2015)

Authors:: Cheng, Michael L.; Zhang, Li; Borok, Margaret; Chokunonga, Eric; Dzamamala, Charles; Korir, Anne; Wabinga, Henry R.; Hiatt, Robert A.; Parkin, D. Max; Van Loon, Katherine
Journal:: Cancer epidemiology
Issue:: Volume 39:Issue 2(2015)
Page Start:: 143
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Two New γ Chain Variants: Hb F-Augusta GA [Gγ59(E3)Lys → Arg; HBG2: c.179A > G] and Hb F-Port Royal-II [Aγ125(H3)Glu → Ala; HBG1: c.377A > C]. (October 2014)

Authors:: Kutlar, Ferdane; Ameri, Afshin; Patel, Niren H.; Zhuang, Lina; Johnson, Lee E.; Cheng, Michael L.; Kutlar, Abdullah
Journal:: Hemoglobin
Issue:: Volume 38:Number 5(2014)
Page Start:: 376
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗